[ACL] YoY Quarter Result on 30-Jun-2024 [#Q4]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
28-Jun-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q4]
Profit Trend
QoQ- 0.00%
YoY- -9.44%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
Revenue 179,550 336,760 457,603 328,798 244,017 -7.37%
PBT 14,280 15,554 69,956 5,379 35,108 -20.12%
Tax 4,696 4,994 21,842 2,063 -9,408 -
NP 9,491 10,480 48,030 3,300 44,455 -32.00%
Tax Rate -32.88% -32.11% -31.22% -38.35% 26.80% -
Total Cost 170,059 326,280 409,573 325,498 199,562 -3.91%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
NP Margin 5.29 3.11 10.50 1.00 18.22 -26.57%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
EPS 0.05 0.05 0.24 0.02 0.22 -30.93%
EPS Diluted 0.05 0.05 0.24 0.02 0.22 -30.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.